drugset / Trial / NCT01103245
Aldosterone and the Metabolic Syndrome
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to determine the effects of mineralocorticoid receptor (MR) antagonism and renin inhibition on glucose metabolism in humans.
Timeline
- Start
- 2010-03
- Primary completion
- 2012-07
- Completion
- 2013-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aliskiren | Small molecule | 150 mg | — |
| Comparator | Aliskiren | Small molecule | 300 mg | — |
| Comparator | Spironolactone | Small molecule | 25 mg | — |
| Comparator | Spironolactone | Small molecule | 50 mg | — |
| Comparator | Hydrochlorothiazide | Unknown | 12.5 mg | — |